B. Riley Securities Initiates Coverage On Strata Critical Medical with Buy Rating, Announces Price Target of $8
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
B. Riley Securities analyst Yuan Zhi initiates coverage on Strata Critical Medical (NASDAQ:SRTA) with a Buy rating and announces Price Target of $8.
B. Riley Securities analyst Yuan Zhi initiates coverage on Strata Critical Medical (NASDAQ:SRTA) with a Buy rating and announces Price Target of $8.
